darunavir has been researched along with 2019 Novel Coronavirus Disease in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 38 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andena, AM; Cattadori, E; Cavanna, L; Citterio, C; Codeluppi, M; Cremona, G; Gubbelini, M; Maniscalco, P; Muroni, L; Muroni, M; Nolli, M; Nunzio, CD; Pedrazzini, G; Schiavo, R | 1 |
| Chen, W; Deng, M; Lin, J; Lv, X; Shen, L; Shen, P; Zhang, Y | 1 |
| Cen, S; Guo, S; Li, Q; Ma, L; Wang, J; Wang, Y; Xie, Y; Yi, D; Zhang, Y; Zhao, J; Zhu, M | 1 |
| Elhadad, H; Hien, NM; Huy, NT; Tam, DNH; Tran, L | 1 |
| Gautam, RK; Jain, V; Mishra, DK; Pareek, A; Rajput, A; Ratan, Y | 1 |
| Cai, JP; Chen, C; Gao, N; Hu, GX; Lin, Q; Xie, SL; Xu, RA; Yang, YJ; Zhu, X | 1 |
| Cravedi, P; Degli Antoni, A; Delsante, M; Fiaccadori, E; Gandolfini, I; Maggiore, U; Manenti, L; Peruzzi, L; Riella, LV; Zaza, G | 1 |
| Iselin, HU; Piunno, A; Spezzani, V | 1 |
| Bagalà, A; Bartiromo, M; Bartoloni, A; Borchi, B; Botta, A; Bresci, S; Cavallo, A; Cirami, C; Cutruzzulà, R; Larti, A; Lugli, G; Tilli, M; Vaglio, A; Xhaferi, B | 1 |
| Costanzo, M; De Giglio, MAR; Roviello, GN | 1 |
| Bernacchia, D; Cattaneo, D; Conti, F; Gervasoni, C; Lupo, A; Merli, S; Pezzati, L; Riva, A; Rusconi, S; Siano, M; Sollima, S | 1 |
| Betti, M; Danzi, GB; Dellanoce, C; Giorgi-Pierfranceschi, M; Morandini, R; Palareti, G; Pan, A; Paoletti, O; Prandoni, P; Tala, M; Testa, S | 1 |
| Ahsan, W; Alhazmi, HA; Bratty, MA; Javed, S; Najmi, A | 1 |
| Bickel, M; Gillor, D; Grunwald, S; Härter, G; Hoffmann, C; Krznaric, I; Mueller, MC; Müller, M; Postel, N; Roider, J; Römer, K; Schabaz, F; Schewe, K; Spinner, CD | 1 |
| Anselmi, E; Cavanna, L; Citterio, C; Codeluppi, M; Stroppa, EM; Toscani, I; Zaffignani, E | 1 |
| Andini, R; Bertolino, L; Corcione, A; Durante-Mangoni, E; Florio, LL; Mele, F; Murino, P; Zampino, R | 1 |
| Chen, C; Chen, M; Cheng, C; Chi, Y; Hu, Z; Huang, S; Jiao, D; Liang, C; Liu, Y; Lv, Y; Sun, W; Wei, H; Yi, Y; Zhang, X | 1 |
| Bojkova, D; Buyck, C; Ciesek, S; Cinatl, J; De Meyer, S; Van Damme, E; Van Loock, M; Woodfall, B | 1 |
| Almasri, H; Ata, F; Sajid, J; Yousaf, Z | 1 |
| Cipriani, MS; Massabeti, R; Valenti, I | 1 |
| Danzi, GB; Di Tano, G; Gherbesi, E; Loffi, M; Moschini, L; Regazzoni, V | 1 |
| Finn, AV; Guagliumi, G; Pellegrini, D; Pescetelli, I; Sonzogni, A | 1 |
| Acosta, S; Dunk, C; Kala, S; Serghides, L | 1 |
| Caselli, E; De Giorgi, A; De Giorgio, R; Di Simone, E; Fabbian, F; Greco, S; Manfredini, R; Passaro, A; Zuliani, G | 1 |
| Talluri, S | 1 |
| Alessandrini, AI; Baldi, F; Balletto, E; Barisione, E; Bassetti, M; Beltramini, S; Berruti, M; Briano, F; Bruzzone, B; Camera, M; Da Rin, G; De Maria, A; Delfino, E; Dentone, C; Dettori, S; Di Biagio, A; Dodi, F; Ferrazin, A; Giacobbe, DR; Giacomini, M; Gratarola, A; Icardi, G; Labate, L; Magnasco, L; Mazzarello, G; Mikulska, M; Mirabella, M; Mora, S; Nicolini, LA; Orsi, A; Pelosi, P; Pincino, R; Portunato, F; Rosseti, N; Russo, C; Sasso, E; Schenone, E; Sepulcri, C; Signori, A; Sormani, MP; Taramasso, L; Toscanini, F; Tutino, S; Vena, A | 1 |
| Bazzoli, F; Cescon, M; Cristini, F; Dajti, E; Tamanini, G; Tamè, M | 1 |
| Biasizzo, J; Cojutti, PG; Della Siega, P; Fabris, M; Givone, F; Londero, A; Pea, F; Tascini, C | 2 |
| Chen, F; Chen, Y; Fang, Q; Hu, S; Jiang, J; Liang, T; Lu, S; Sheng, J; Wei, N; Wu, L; Zheng, S; Zhou, J | 1 |
| Ferrari, SA; Muzzarelli, L; Piconi, S; Rossi, G; Sommaruga, S | 1 |
| Choi, EY; Choi, SH; Kim, EJ; Kim, Y; Kwon, YS; Lee, J; Lee, SY; Park, JS | 1 |
| Emanuela, C; Francesco, L; Giorgia, G; Pasquale, N; Roberto, P; Sara, D | 1 |
| Hirano, Y; Komatsu, TS; Koyama, YM; Morimoto, G; Ohno, Y; Okimoto, N; Taiji, M | 1 |
| Aureau, I; Bernard, N; Bonnet, F; Bouchet, S; Contis, A; Hessamfar, M; Lahouati, M; Lapoirie, J; Meriglier, E; Pedeboscq, S; Rivoisy, C; Sacher, F; Sacristan, B; Vandenhende, MA | 1 |
| Cattaneo, D; Corbellino, M; Cozzi, V; Fusi, M; Gervasoni, C | 1 |
| Angkasekwinai, N; Assanasen, S; Chayakulkeeree, M; Chierakul, N; Horthongkham, N; Jitmuang, A; Kantakamalakul, W; Koomanachai, P; Ratanarat, R; Rattanaumpawan, P; Rongrungruang, Y; Sirijatuphat, R; Suputtamongkol, Y; Wangchinda, W | 1 |
| Bellavita, G; Bonzi, L; Buoite Stella, A; Cecotti, L; D Acunto, L; Fabris, M; Furlanis, G; Manganotti, P; Pesavento, V; Sartori, A; Tommasini, V | 1 |
3 review(s) available for darunavir and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Promising Repurposed Antiviral Molecules to Combat SARS-CoV-2: A Review.
Topics: Antiviral Agents; COVID-19; Darunavir; Humans; Protease Inhibitors; SARS-CoV-2 | 2023 |
Treatment of SARS-CoV-2: How far have we reached?
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Chloroquine; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferon-alpha; Interferon-beta; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2 | 2020 |
Current treatment of COVID-19 in renal patients: hope or hype?
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Drug Combinations; Humans; Kidney; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Renal Insufficiency, Chronic; Renal Replacement Therapy; Ritonavir | 2020 |
35 other study(ies) available for darunavir and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
COVID-19 Outbreak in Italy: Report on the First 124 Consecutive Patients Treated at Home.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Cobicistat; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Darunavir; Disease Outbreaks; Drug Combinations; Female; Home Care Services; Hospitalization; Humans; Hydroxychloroquine; Italy; Male; Middle Aged; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Telemedicine; Young Adult | 2021 |
Epidemiology, diagnosis and treatment of early COVID-19 patients in Jiaxing City, Zhejiang Province, China, January to March 2020.
Topics: China; Cities; Cobicistat; COVID-19; Darunavir; Female; Humans; Lopinavir; Male; Middle Aged; Retrospective Studies; Ritonavir | 2022 |
Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CL
Topics: Antiviral Agents; Coronavirus 3C Proteases; COVID-19; Darunavir; Humans; Molecular Docking Simulation; Protease Inhibitors; SARS-CoV-2 | 2022 |
Evaluation of COVID-19 protease and HIV inhibitors interactions.
Topics: Antiviral Agents; Atazanavir Sulfate; COVID-19; Darunavir; Humans; Lopinavir; Molecular Docking Simulation; Peptide Hydrolases; Protease Inhibitors | 2022 |
Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro.
Topics: Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Darunavir; Drug Interactions; Genetic Variation; Humans; Itraconazole; Lopinavir; Tandem Mass Spectrometry | 2023 |
COVID-19 in kidney transplant recipients.
Topics: Aged; Betacoronavirus; Cobicistat; Colchicine; Coronavirus Infections; COVID-19; Cytokines; Darunavir; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lopinavir; Male; Middle Aged; Mycophenolic Acid; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Tacrolimus; Transplant Recipients; Treatment Outcome | 2020 |
Benign COVID-19 in an immunocompromised cancer patient - the case of a married couple.
Topics: Anti-Bacterial Agents; Antiviral Agents; Betacoronavirus; Breast Neoplasms; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Critical Care; Darunavir; Dyspnea; Emergency Service, Hospital; Female; Fever; Humans; Hydroxychloroquine; Immunocompetence; Immunocompromised Host; Male; Middle Aged; Neoplasm Recurrence, Local; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spouses; Treatment Outcome | 2020 |
Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19).
Topics: Adult; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Ciliopathies; Cobicistat; Common Cold; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A Inhibitors; Darunavir; Deprescriptions; Drug Combinations; Drug Interactions; Enzyme Inhibitors; Fatigue; Female; Glucocorticoids; Graft Rejection; Humans; Hydroxychloroquine; Immunocompromised Host; Immunosuppressive Agents; Interleukin-10; Interleukin-1beta; Interleukin-6; Interleukin-8; Kidney Diseases, Cystic; Kidney Failure, Chronic; Kidney Transplantation; Leber Congenital Amaurosis; Lopinavir; Methylprednisolone; Optic Atrophies, Hereditary; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Severity of Illness Index; Tacrolimus | 2020 |
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Humans; Hydroxychloroquine; Indoles; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2 | 2020 |
Darunavir does not prevent SARS-CoV-2 infection in HIV patients.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Darunavir; HIV Infections; Humans; Lopinavir; Pandemics; Pneumonia, Viral; Republic of Korea; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; SARS-CoV-2 | 2020 |
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antithrombins; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Dabigatran; Darunavir; Drug Interactions; Drug Monitoring; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Italy; Lopinavir; Male; Pandemics; Patient Safety; Pneumonia, Viral; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Risk Factors; Ritonavir; SARS-CoV-2; Severity of Illness Index; Thiazoles | 2020 |
COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; Betacoronavirus; Coinfection; Coronavirus Infections; COVID-19; Darunavir; Female; HIV; HIV Infections; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Tenofovir; Viral Load | 2020 |
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy).
Topics: Age Factors; Aged; Aged, 80 and over; Antiviral Agents; Azithromycin; Betacoronavirus; Ceftriaxone; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Therapy, Combination; Female; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Italy; Lopinavir; Male; Methylprednisolone; Middle Aged; Neoplasms; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Early experience with remdesivir in SARS-CoV-2 pneumonia.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Chemical and Drug Induced Liver Injury; Convalescence; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Drug Administration Schedule; Drug Combinations; Fatal Outcome; Humans; Hydroxychloroquine; Lopinavir; Multiple Organ Failure; Pandemics; Pneumonia, Viral; Ritonavir; RNA, Viral; SARS-CoV-2; Torsades de Pointes | 2020 |
A special symptom of olfactory dysfunction in coronavirus disease 2019: report of three cases.
Topics: Adolescent; Adult; Antiviral Agents; Betacoronavirus; China; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Female; Humans; Indoles; Male; Methylprednisolone; Olfaction Disorders; Pandemics; Pneumonia, Viral; SARS-CoV-2; Taste Disorders; Treatment Outcome; Vitamin B 12 | 2020 |
Lack of antiviral activity of darunavir against SARS-CoV-2.
Topics: Antiviral Agents; Betacoronavirus; Cell Line; Cell Survival; Coronavirus Infections; COVID-19; Darunavir; Humans; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
COVID-19 presenting with diarrhoea and hyponatraemia.
Topics: Abdominal Pain; Adult; Antimalarials; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; Darunavir; Diagnosis, Differential; Diarrhea; Humans; Hyponatremia; Male; Pandemics; Pneumonia, Viral; Ribavirin; SARS-CoV-2; Treatment Outcome | 2020 |
Covid-19: A systemic disease treated with a wide-ranging approach: A case report.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Azithromycin; China; Coronavirus Infections; COVID-19; Darunavir; Disease Progression; Enoxaparin; Humans; Hydroxychloroquine; Male; Middle Aged; Noninvasive Ventilation; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; Ritonavir | 2020 |
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; COVID-19; COVID-19 Drug Treatment; Darunavir; Electrocardiography; Enzyme Inhibitors; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Male; Middle Aged; Ritonavir; SARS-CoV-2 | 2021 |
Microthrombi and ST-Segment-Elevation Myocardial Infarction in COVID-19.
Topics: Adult; Antiviral Agents; Betacoronavirus; C-Reactive Protein; Cobicistat; Coronavirus Infections; COVID-19; Darunavir; Electrocardiography; Female; Humans; Hypokinesia; Hypotension; International Normalized Ratio; Myocardium; Nasopharynx; Pandemics; Platelet Count; Pneumonia, Viral; SARS-CoV-2; ST Elevation Myocardial Infarction; Thrombosis; Troponin I; Ventricular Dysfunction, Left | 2020 |
Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies.
Topics: Animals; Betacoronavirus; Cells, Cultured; Clinical Trials as Topic; Coculture Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Decidua; Disease Models, Animal; Drug Repositioning; Drug Therapy, Combination; Embryo Implantation; Endometrium; Female; HIV Infections; Humans; Lopinavir; Maternal Exposure; Mice; Pandemics; Placentation; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Primary Cell Culture; SARS-CoV-2; Trophoblasts; Vascular Remodeling | 2020 |
Morning vs. evening administration of antiviral therapy in COVID-19 patients. A preliminary retrospective study in Ferrara, Italy.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Betacoronavirus; Blood Gas Analysis; C-Reactive Protein; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Chronotherapy; Drug Therapy, Combination; Hospital Mortality; Humans; Italy; Length of Stay; Leukocyte Count; Middle Aged; Oxygen; Pandemics; Partial Pressure; Pneumonia, Viral; Retrospective Studies; Ritonavir; SARS-CoV-2 | 2020 |
Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19.
Topics: Antiviral Agents; Benzazepines; COVID-19; COVID-19 Drug Treatment; Cyclopropanes; Darunavir; Drug Evaluation, Preclinical; Drug Repositioning; High-Throughput Screening Assays; Humans; Indoles; Isoindoles; Lactams, Macrocyclic; Molecular Docking Simulation; Proline; Saquinavir; SARS-CoV-2; Sulfonamides | 2021 |
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antimalarials; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Darunavir; Female; Follow-Up Studies; HIV Protease Inhibitors; Humans; Hydroxychloroquine; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Treatment Outcome | 2020 |
COVID-19 in a young liver transplant recipient: caution for drug-drug interactions.
Topics: Acute Kidney Injury; Adult; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Drug Interactions; Drug Monitoring; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver Transplantation; Male; Pandemics; Pneumonia, Viral; Prednisone; Risk Adjustment; Ritonavir; SARS-CoV-2; Tacrolimus; Transplant Recipients; Treatment Outcome | 2020 |
Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6.
Topics: Adult; Age Factors; Aged; Betacoronavirus; Body Weights and Measures; Comorbidity; Coronavirus Infections; COVID-19; Cytochrome P-450 CYP3A; Darunavir; Dose-Response Relationship, Drug; Female; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-6; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Monte Carlo Method; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Sex Factors | 2020 |
First report of manic-like symptoms in a COVID-19 patient with no previous history of a psychiatric disorder.
Topics: Antibodies, Viral; Antipsychotic Agents; Antiviral Agents; Betacoronavirus; Bipolar Disorder; Brain; Chest Pain; China; Clinical Laboratory Techniques; Cobicistat; Coronavirus Infections; COVID-19; COVID-19 Testing; Darunavir; Dyspnea; Fever; Glucocorticoids; Humans; Indoles; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Moxifloxacin; Olanzapine; Pandemics; Pharyngitis; Pneumonia, Viral; Reverse Transcriptase Polymerase Chain Reaction; SARS-CoV-2 | 2020 |
An infection-oriented approach for thoracic endovascular aortic repair in a SARS-CoV-2 positive patient. A case report.
Topics: Anesthesia, Local; Antibiotic Prophylaxis; Anticoagulants; Antiviral Agents; Aortic Aneurysm, Thoracic; Aortic Dissection; Betacoronavirus; Blood Vessel Prosthesis Implantation; Contraindications, Procedure; Coronavirus Infections; COVID-19; Darunavir; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Endovascular Procedures; Enoxaparin; Female; Humans; Hydroxychloroquine; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Intraoperative Complications; Intubation, Intratracheal; Middle Aged; Nasopharynx; Operating Rooms; Pandemics; Patient Isolation; Pneumonia, Viral; Ritonavir; SARS-CoV-2; Spinal Cord Ischemia; Vertebral Artery | 2020 |
Use of Darunavir-Cobicistat as a Treatment Option for Critically Ill Patients with SARS-CoV-2 Infection.
Topics: Adult; Anti-HIV Agents; Betacoronavirus; Case-Control Studies; Cobicistat; Coronavirus Infections; COVID-19; Critical Illness; Darunavir; Female; HIV Protease Inhibitors; Humans; Intensive Care Units; Male; Middle Aged; Pandemics; Pneumonia, Viral; Republic of Korea; Retrospective Studies; SARS-CoV-2; Severity of Illness Index; Treatment Outcome | 2020 |
Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation.
Topics: Betacoronavirus; Binding Sites; Biophysical Phenomena; Catalytic Domain; Computational Biology; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; Cysteine Endopeptidases; Darunavir; Drug Repositioning; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Molecular Dynamics Simulation; Nelfinavir; Pandemics; Pneumonia, Viral; Ritonavir; Saquinavir; SARS-CoV-2; Viral Nonstructural Proteins | 2020 |
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
Topics: Antiviral Agents; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Therapy, Combination; Electrocardiography; France; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; SARS-CoV-2; Severity of Illness Index; Treatment Outcome | 2021 |
Authors' Reply to Cattaneo et al.: "Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6".
Topics: COVID-19; Darunavir; HIV Infections; Humans; Interleukin-6; SARS-CoV-2 | 2021 |
Comment on "Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6".
Topics: COVID-19; Darunavir; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-6; Ritonavir; SARS-CoV-2 | 2021 |
Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand's university-based referral hospital.
Topics: Adult; Aged; Aged, 80 and over; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Darunavir; Disease Progression; Drug Combinations; Female; Hospitals; Hospitals, University; Humans; Hydroxychloroquine; Lopinavir; Male; Middle Aged; Pyrazines; Referral and Consultation; Retrospective Studies; Ritonavir; Thailand; Treatment Outcome; Young Adult | 2021 |
Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathy patients.
Topics: Action Potentials; Acute Disease; Aged; Anti-Bacterial Agents; Biomarkers; Convalescence; COVID-19; COVID-19 Drug Treatment; Darunavir; Drug Combinations; Guillain-Barre Syndrome; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Interleukin-6; Interleukin-8; Lopinavir; Male; Neural Conduction; Peripheral Nervous System; Prognosis; Respiratory Insufficiency; Ritonavir; SARS-CoV-2 | 2021 |